Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Pompe Disease Registry Protocol

View source ↗

Summary

This entry describes a Pompe disease registry protocol sponsored by Genzyme (a Sanofi company). The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Glycogen Storage Disease Type II, Pompe Disease | Status: RECRUITING